SimBioSys Secures FDA Clearance for TumorSight® Risk, Introducing the World’s First AI-Powered, MRI-Derived Breast Cancer Recurrence Risk Assessment

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, placed second in a renowned international competition on automated image analysis called the Camelyon Challenge. The competition...

I don’t remember how. I don’t remember where I got the idea. I only remember the why. When I was 10 and my grandfather was turning 65, heading into retirement after a lifetime of orphanages, foster homes, depression and recession, war and...

Join us for breakfast and a talk on Antibodies to Artificial Intelligence, May 22, 2018 – 7am to 8am –  Grand Ballroom 1 Today, both Industry and Academia are heavily investing in Artificial Intelligence (AI). Machine learning has...

In some previous posts going back nearly 4 years I mentioned my father’s jewelry store in the heart of Chicago’s downtown jewelry district. I talked about his customers, in particular, gypsies who would frequent the store with cash and a...

Huron Digital Pathology announced today that Dr. Hamid Tizhoosh, Director of the KIMIA Lab at the University of Waterloo and Huron advisory board member, will present a talk entitled “Faster, Better, More Reliable than Deep Features: A...

When: Wed, Jun 6, 2018 10:00 AM - 11:00 AM PDT Register Now   PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in determining...